AXSOME THERAPEUTICS
Axsome Therapeutics is a biopharmaceutical company developing novel therapies for the treatment of pain and other neurological diseases. By focusing on this therapeutic area, Axsome is addressing growing markets where current treatment options are limited or inadequate. Axsome has a balanced portfolio of clinical development stage as well as research stage products. Axsome Therapeutics aims to become a fully integrated biopharmaceutical company that develops and commercializes differentiated products which increase the armamentarium of caregivers and improve the lives of patients. While the focus of the company is on developing its internally derived product candidates, Axsome also evaluates potential in-licensing opportunities to supplement its current portfolio.
AXSOME THERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2012-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.axsome.com
Total Employee:
251+
Status:
Active
Contact:
+1 (212) 203-5072
Email Addresses:
[email protected]
Total Funding:
431.99 M USD
Technology used in webpage:
HSTS IPv6 CrUX Top 50m Common Name Invalid Microsoft CloudFront Amazon Route 53 DigiCert SSL Akamai Hosted Visual Studio
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Innovent Biologics
Innovent Biologics is a biopharmaceutical company that develops and manufactures monoclonal antibodies.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-05-28 | SUNOSI | SUNOSI acquired by Axsome Therapeutics | 53 M USD |
Official Site Inspections
http://www.axsome.com Semrush global rank: 1.98 M Semrush visits lastest month: 10.63 K
- Host name: 199.189.226.117
- IP address: 199.189.226.117
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Axsome Therapeutics"
Axsome Therapeutics - Crunchbase Company Profile
Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.See details»
Login - axsomeproviderportal.com
Copyright © 2023 Axsome Therapeutics. All rights reserved. This site is intended for U.S. residents only.See details»
Login Template Title
Login Template TitleLoading × Sorry to interrupt CSS Error RefreshSee details»
Benefits Summary - Axsome
This Benefits Summary is intended to summarize key features of benefits that are available to Axsome employees under the applicable plan document or Axsome policy. If there is any conflict …See details»
Careers - Axsome Therapeutics
Interested in joining Axsome Therapeutics? Take a look at the current opportunities and submit your CV and cover letter.See details»
Current Career Opportunities - Axsome Therapeutics
Axsome Therapeutics, Inc. is a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders. The Axsome team is a lean, dynamic group of individuals committed to …See details»
Axsome bounces back as FDA clears depression drug
3 days ago Shares in Axsome Therapeutics have rocketed on FDA approval of its depression therapy Auvelity (formerly AXS-05) – a year after its approval was held up by the regulator. The FDA has cleared ...See details»
301 Moved Permanently
Moved PermanentlyThe document has moved here.See details»
Axsome Therapeutics 10K 2024 Annual report | AXSM Filing
Feb 18, 2025 In addition, according to the World Health Organization, or WHO, depression is the leading cause of disability worldwide and is a major contributor to the overall global burden of …See details»
Rachel Pottow - Director at Axsome Therapeutics, Inc.
Director at Axsome Therapeutics, Inc. · Experience: Axsome Therapeutics, Inc. · Education: Columbia University Mailman School of Public Health · Location: New York · 500+ connections on ...See details»
Working at Axsome Therapeutics - Zippia
Mar 14, 2024 Find out what it's like to work at Axsome Therapeutics. See what kind of people work at Axsome Therapeutics, career paths working at Axsome Therapeutics, company culture, …See details»
About Axsome - Axsome Therapeutics
See how Axsome is transforming the CNS treatment approach by developing therapeutic options that improve patients’ lives in a meaningful way.See details»
Ashley Dong - Axsome Therapeutics, Inc. | LinkedIn
Experience: Axsome Therapeutics, Inc. · Education: Princeton University · Location: United States · 500+ connections on LinkedIn. View Ashley Dong’s profile on LinkedIn, a professional ...See details»
Axsome Therapeutics Reports Second Quarter 2025 Financial Results …
5 days ago “Axsome delivered robust second quarter performance, reflecting strong underlying demand for our life-changing medicines, exacting commercial execution, solid regulatory …See details»
Axsome Therapeutics Reports Second Quarter 2025 ... - Seeking Alpha
5 days ago “Axsome delivered robust second quarter performance, reflecting strong underlying demand for our life-changing medicines, exacting commercial execution, solid regulatory …See details»
Axsome Therapeutics, Inc. (AXSM) Stock Price, News, Quote
Find the latest Axsome Therapeutics, Inc. (AXSM) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Axsome Therapeutics - Financial Details - Crunchbase
Nov 20, 2015 Axsome Therapeutics is a biopharmaceutical company that develops therapies for the management and treatment of neurological disorders.See details»
4 Annual Report
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024See details»
Axsome Therapeutics Reports Second Quarter 2025 Financial
5 days ago Axsome will host a conference call and webcast today at 8:00 a.m. Eastern Time to discuss its second quarter 2025 financial results and provide a business update.See details»
Axsome Therapeutics Champions Brain Health During Alzheimer's
Jun 20, 2025 During Alzheimer’s & Brain Awareness Month, Axsome is working with advocacy and patient communities to raise awareness and share resources, in addition to participating at …See details»